167.41
price down icon0.78%   -1.32
after-market アフターアワーズ: 167.41
loading
前日終値:
$168.73
開ける:
$166.76
24時間の取引高:
941.43K
Relative Volume:
0.85
時価総額:
$18.72B
収益:
$9.54B
当期純損益:
$841.00M
株価収益率:
22.50
EPS:
7.44
ネットキャッシュフロー:
$1.02B
1週間 パフォーマンス:
-2.61%
1か月 パフォーマンス:
-6.80%
6か月 パフォーマンス:
+2.64%
1年 パフォーマンス:
+17.65%
1日の値動き範囲:
Value
$166.76
$170.14
1週間の範囲:
Value
$165.78
$173.04
52週間の値動き範囲:
Value
$142.86
$182.38

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
名前
Quest Diagnostics Inc
Name
セクター
Healthcare (1161)
Name
電話
(973) 520-2700
Name
住所
500 PLAZA DRIVE, SECAUCUS
Name
職員
56,000
Name
Twitter
@QuestDX
Name
次回の収益日
2025-07-22
Name
最新のSEC提出書
Name
DGX's Discussions on Twitter

DGX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
167.41 18.87B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
467.68 180.17B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
197.16 146.07B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
534.31 46.01B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
114.81 33.53B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
185.86 32.56B 15.50B 1.33B 2.16B 7.34

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-02 開始されました Redburn Atlantic Buy
2025-03-04 ダウングレード Citigroup Buy → Neutral
2025-01-06 アップグレード Leerink Partners Market Perform → Outperform
2024-12-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました Jefferies Buy
2024-10-23 アップグレード Robert W. Baird Neutral → Outperform
2024-08-28 再開されました Evercore ISI In-line
2024-07-10 アップグレード Citigroup Neutral → Buy
2024-02-26 開始されました Leerink Partners Market Perform
2024-02-07 アップグレード Jefferies Hold → Buy
2024-01-03 開始されました Barclays Equal Weight
2023-12-12 アップグレード BofA Securities Neutral → Buy
2023-06-29 開始されました Piper Sandler Neutral
2023-05-02 ダウングレード BofA Securities Buy → Neutral
2023-04-03 アップグレード Citigroup Sell → Neutral
2023-01-23 開始されました Evercore ISI In-line
2022-11-17 ダウングレード Citigroup Neutral → Sell
2022-08-22 再開されました Morgan Stanley Equal-Weight
2022-04-04 ダウングレード Citigroup Buy → Neutral
2022-02-23 ダウングレード UBS Buy → Neutral
2022-02-02 ダウングレード Jefferies Buy → Hold
2022-01-28 ダウングレード Deutsche Bank Buy → Hold
2021-05-04 アップグレード UBS Neutral → Buy
2021-03-12 ダウングレード Robert W. Baird Outperform → Neutral
2020-10-21 アップグレード Argus Hold → Buy
2020-07-29 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 アップグレード BofA Securities Neutral → Buy
2020-06-09 アップグレード Wells Fargo Underweight → Equal Weight
2020-06-02 アップグレード Deutsche Bank Hold → Buy
2020-04-28 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-04-27 アップグレード Citigroup Neutral → Buy
2020-04-27 アップグレード Wolfe Research Underperform → Peer Perform
2020-03-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-01-08 開始されました Wells Fargo Underweight
2020-01-07 ダウングレード Barclays Overweight → Equal Weight
2019-12-19 アップグレード BofA/Merrill Underperform → Neutral
2019-07-15 ダウングレード Goldman Neutral → Sell
2019-04-02 アップグレード Jefferies Hold → Buy
2019-03-18 再開されました Credit Suisse Neutral
2019-01-31 ダウングレード Argus Buy → Hold
2019-01-17 開始されました UBS Neutral
2019-01-03 ダウングレード BofA/Merrill Neutral → Underperform
2018-12-03 ダウングレード BofA/Merrill Buy → Neutral
2018-11-30 ダウングレード Goldman Buy → Neutral
すべてを表示

Quest Diagnostics Inc (DGX) 最新ニュース

pulisher
Jul 30, 2025

Drug Abuse Testing Market Forecast and Company Analysis - GlobeNewswire

Jul 30, 2025
pulisher
Jul 30, 2025

Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance

Jul 30, 2025
pulisher
Jul 29, 2025

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing - Financial Times

Jul 29, 2025
pulisher
Jul 29, 2025

North America Autoimmune Disease Diagnostics Market Report - GlobeNewswire

Jul 29, 2025
pulisher
Jul 29, 2025

North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers - Yahoo Finance

Jul 29, 2025
pulisher
Jul 28, 2025

What makes Quest Diagnostics Incorporated stock price move sharplyTrade Setups With Clear Risk Limits Highlighted - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Quest Diagnostics Incorporated stockInvest smarter with real-time trading alerts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Why is Quest Diagnostics Incorporated stock attracting strong analyst attentionTremendous portfolio expansion - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 06:28:08 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Quest Diagnostics IncorporatedUnlock powerful stock screening techniques - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive Quest Diagnostics Incorporated stock higher in 2025Sky-high profits - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Quest Diagnostics (NYSE:DGX) Stock Price - MarketBeat

Jul 27, 2025
pulisher
Jul 25, 2025

Quest Diagnostics Incorporated Stock Analysis and ForecastPhenomenal capital gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Quest Diagnostics Incorporated stockDynamic growth stocks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

How high can Quest Diagnostics Incorporated stock price go in 2025High-performance investment picks - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Quest Diagnostics Trading Volume Drops 31.43% to $364 Million Ranking 317th Despite Stock Price Rise - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Options Corner: Quest Diagnostics' Post-Earnings Digestion Drama Opens A Science-Backed Opportunity - inkl

Jul 24, 2025
pulisher
Jul 24, 2025

Quest Diagnostics’ revenue up 15.2% to USD 2.76B in Q2 2025 - Medical Buyer

Jul 24, 2025
pulisher
Jul 24, 2025

Barclays Reaffirms Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus

Jul 24, 2025
pulisher
Jul 23, 2025

Quest Diagnostics Incorporated's (NYSE:DGX) Shares May Have Run Too Fast Too Soon - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

Quest Diagnostics (DGX) Price Target Raised by UBS, Rating Maint - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

U.S. DTC Wellness Testing Market Forecast to 2030: A $1.91 - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Quest Diagnostics (DGX) Price Target Raised by Deutsche Bank Ana - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - ADVFN Brasil

Jul 23, 2025
pulisher
Jul 23, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 23, 2025
pulisher
Jul 23, 2025

Quest Diagnostics (DGX) Price Target Raised by Deutsche Bank | D - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Is Quest Diagnostics Incorporated a good long term investmentConsistently exceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Quest Diagnostics Inc (DGX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Quest Diagnostics Inc (DGX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... By GuruFocus - Investing.com Canada

Jul 23, 2025
pulisher
Jul 23, 2025

DGX Q2 Deep Dive: Acquisitions, Advanced Diagnostics, and Utilization Trends Drive Growth - TradingView

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Quest Diagnostics Incorporated stock priceBreakthrough financial growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics Lifts Outlook As Testing Demand Grows - Finimize

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics Surges to 241st in Daily Rankings with $476 Million Turnover - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics Well Positioned to Benefit From Strong Medical Utilization - Morningstar

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics Q2 EarningsQuest Diagnostics (NYSE:DGX) - Benzinga

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics Reports Strong Q2 Earnings, Exceeds ExpectationsNews and Statistics - IndexBox

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics: Q2 Earnings Snapshot - Chron

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics rises on upbeat results, guidance raise (DGX:NYSE) - Seeking Alpha

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand - whbl.com

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

What to Expect From Quest Diagnostics' Q2 2025 Earnings Report - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Quest Diagnostics (DGX) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Jul 22, 2025

Quest Diagnostics Inc (DGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$133.66
price down icon 5.18%
diagnostics_research WAT
$288.76
price down icon 3.45%
diagnostics_research LH
$260.08
price down icon 1.45%
diagnostics_research MTD
$1,233.68
price down icon 2.55%
diagnostics_research IQV
$185.86
price down icon 2.97%
大文字化:     |  ボリューム (24 時間):